A subsidiary of Zhejiang Medicine becomes a shareholder of Sirui Biological

On 20 June, 2015, Zhejiang Xianju Pharmaceutical Co., Ltd. (Xianju Pharmaceutical), a subsidiary of Zhejiang Medicine Co., Ltd. announced that it planned to invest USD4.9 million(RMB30 million) in Shandong Sirui Biological Medicine Co., Ltd (Sirui Bi...

More from CCM

www.cnchemicals.com